[go: up one dir, main page]

PL3560937T3 - Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA i metody diagnostyczne je wykorzystujące - Google Patents

Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA i metody diagnostyczne je wykorzystujące

Info

Publication number
PL3560937T3
PL3560937T3 PL19179758.8T PL19179758T PL3560937T3 PL 3560937 T3 PL3560937 T3 PL 3560937T3 PL 19179758 T PL19179758 T PL 19179758T PL 3560937 T3 PL3560937 T3 PL 3560937T3
Authority
PL
Poland
Prior art keywords
methods
preparing
imaging agents
pet imaging
therewith
Prior art date
Application number
PL19179758.8T
Other languages
English (en)
Inventor
Clifford BERKMAN
Svetlana A. Stekhova
Original Assignee
Cancer Targeted Technology Llc
Washington State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Targeted Technology Llc, Washington State University filed Critical Cancer Targeted Technology Llc
Publication of PL3560937T3 publication Critical patent/PL3560937T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0489Phosphates or phosphonates, e.g. bone-seeking phosphonates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04Organic compounds
    • A61K51/0402Organic compounds carboxylic acid carriers, fatty acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2404Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2404Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2416Esteramides the ester moiety containing a substituent or a structure which is considered as characteristic of cycloaliphatic alcohols
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/22Amides of acids of phosphorus
    • C07F9/24Esteramides
    • C07F9/2454Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/2458Esteramides the amide moiety containing a substituent or a structure which is considered as characteristic of aliphatic amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/58Pyridine rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Optics & Photonics (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL19179758.8T 2013-03-15 2014-03-14 Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA i metody diagnostyczne je wykorzystujące PL3560937T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201361798108P 2013-03-15 2013-03-15

Publications (1)

Publication Number Publication Date
PL3560937T3 true PL3560937T3 (pl) 2023-03-27

Family

ID=50639969

Family Applications (2)

Application Number Title Priority Date Filing Date
PL19179758.8T PL3560937T3 (pl) 2013-03-15 2014-03-14 Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA i metody diagnostyczne je wykorzystujące
PL14721640T PL2970345T3 (pl) 2013-03-15 2014-03-14 Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL14721640T PL2970345T3 (pl) 2013-03-15 2014-03-14 Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA

Country Status (17)

Country Link
US (2) US11554183B2 (pl)
EP (3) EP2970345B1 (pl)
CN (2) CN105308056B (pl)
AU (2) AU2014228233B2 (pl)
CA (1) CA2903131C (pl)
DK (2) DK2970345T3 (pl)
ES (2) ES2937955T3 (pl)
FI (1) FI3560937T3 (pl)
HR (2) HRP20230109T1 (pl)
HU (2) HUE061402T2 (pl)
LT (2) LT2970345T (pl)
PL (2) PL3560937T3 (pl)
PT (2) PT3560937T (pl)
RS (1) RS64011B1 (pl)
SI (2) SI3560937T1 (pl)
SM (1) SMT202300035T1 (pl)
WO (1) WO2014143736A1 (pl)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017027870A1 (en) * 2015-08-13 2017-02-16 The Johns Hopkins University Triazole conjugated ureas, thioureas, carbamates, and "reversed" carbamates for psma-targeted imaging agents and uses thereof
MX2019001053A (es) 2016-08-10 2019-09-23 Cancer Targeted Tech Llc Inhibidores de antigeno de la membrana especifico para la prostata (psma) quelados.
WO2018175646A1 (en) 2017-03-22 2018-09-27 Safeop Surgical, Inc. Medical systems and methods for detecting changes in electrophysiological evoked potentials
WO2018233798A1 (en) 2017-06-20 2018-12-27 ITM Isotopen Technologien München AG NOVEL PSMA BINDING AGENTS AND USE THEREOF
CN110740757B (zh) 2017-05-24 2023-04-04 同位素技术慕尼黑公司 新型psma-结合剂及其用途
WO2020108753A1 (en) 2018-11-28 2020-06-04 ITM Isotopen Technologien München AG Novel tumor antigen binding agents and uses thereof
WO2020224780A1 (en) 2019-05-08 2020-11-12 ITM Isotopen Technologien München AG Para-aminohippuric acid (pah) as a renal protective substance
WO2021046233A1 (en) 2019-09-03 2021-03-11 Cancer Targeted Technology Llc Chelate-containing psma inhibitors
WO2022096103A1 (en) 2020-11-05 2022-05-12 ITM Isotopen Technologien München AG Combination of para-aminohippuric acid (pah) and radiolabeled complexes for treating cancer
WO2022111800A1 (en) 2020-11-25 2022-06-02 Itm Solucin Gmbh Stable formulations for radionuclide complexes
TW202304531A (zh) 2021-04-02 2023-02-01 法商先進加速器應用公司 放射性配體顯像劑在前列腺癌的用途及注射或輸液用溶液
WO2025038752A1 (en) 2023-08-14 2025-02-20 Cancer Targeted Technology Llc Psma binding ligand-linker conjugates and methods for use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1999136B1 (en) * 2006-03-14 2012-10-24 Cancer Targeted Technology LLC Peptidomimetic inhibitors of psma,compounds comprising them, and methods of use
BRPI0716554A2 (pt) * 2006-09-08 2013-09-24 Bayer Schering Pharma Ag compostos de mÉtodos para agentes rotulados de 18f
CA2987744C (en) * 2008-08-01 2022-11-15 The Johns Hopkins University Psma-binding agents and uses thereof
WO2012064914A2 (en) * 2010-11-12 2012-05-18 Washington State University Research Foundation Peptidomimetic inhibitors of psma
CA2839195C (en) * 2011-06-15 2021-10-26 Cancer Targeted Technology Llc Chelated psma inhibitors
CN102757296B (zh) * 2012-04-10 2014-11-19 中国科学院上海应用物理研究所 一种对化合物进行[18f]标记的方法
WO2013173583A1 (en) * 2012-05-16 2013-11-21 Cancer Targeted Technology, Llc Psma inhibitors
WO2013173630A1 (en) * 2012-05-16 2013-11-21 Cancer Targeted Technology, Llc Formulation of radiopharmaceuticals containing multiple acidic groups

Also Published As

Publication number Publication date
EP3560937A1 (en) 2019-10-30
AU2014228233A1 (en) 2015-09-17
CA2903131A1 (en) 2014-09-18
SMT202300035T1 (it) 2023-05-12
SI2970345T1 (sl) 2019-11-29
CN108558939B (zh) 2021-08-24
HUE046194T2 (hu) 2020-02-28
WO2014143736A1 (en) 2014-09-18
US11554183B2 (en) 2023-01-17
LT3560937T (lt) 2023-03-27
AU2019203610A1 (en) 2019-06-13
ES2937955T3 (es) 2023-04-03
CA2903131C (en) 2021-11-23
RS64011B1 (sr) 2023-03-31
EP2970345B1 (en) 2019-06-19
PT2970345T (pt) 2019-09-06
EP4180438A1 (en) 2023-05-17
US20160030605A1 (en) 2016-02-04
EP2970345A1 (en) 2016-01-20
HRP20230109T1 (hr) 2023-04-28
HUE061402T2 (hu) 2023-06-28
CN108558939A (zh) 2018-09-21
CN105308056A (zh) 2016-02-03
US20230144322A1 (en) 2023-05-11
HRP20191482T1 (hr) 2019-11-15
PT3560937T (pt) 2023-02-13
SI3560937T1 (sl) 2023-04-28
CN105308056B (zh) 2018-03-20
AU2014228233B2 (en) 2019-02-28
PL2970345T3 (pl) 2019-12-31
FI3560937T3 (fi) 2023-02-28
AU2019203610B2 (en) 2021-02-04
LT2970345T (lt) 2019-09-25
EP3560937B1 (en) 2022-12-28
DK3560937T3 (da) 2023-02-13
DK2970345T3 (da) 2019-08-26
ES2743433T3 (es) 2020-02-19

Similar Documents

Publication Publication Date Title
PL3560937T3 (pl) Znakowane 18F środki do obrazowania PET ukierunkowane na PSMA i metody diagnostyczne je wykorzystujące
EP2983582A4 (en) METHODS FOR DIAGNOSING SKIN AND IMAGE PROCESSING
GB201304149D0 (en) Ultrasound imaging
GB2517829B (en) CT imaging methods and systems
EP2967280C0 (en) MEDICAL IMAGING DEVICE
EP2948045A4 (en) IMAGING BODY STRUCTURES
IL245691A0 (en) Electromagnetic tomographic imaging that can be worn/carried by a person
GB201404628D0 (en) Medical imaging
IL275368B (en) Diagnosis and treatment of autoimmune diseases
HK1222562A1 (zh) 用於醫學診斷的組合物及方法
GB2515601B (en) Ultrasound imaging apparatus
HK1219636A1 (zh) 經改善的皮膚及頭皮診斷裝置及方法
EP2832303A4 (en) PROBE AND DEVICE FOR DIAGNOSTIC IMAGING
EP2944266A4 (en) ULTRASOUND IMAGING DEVICE
EP2952137A4 (en) ULTRASONIC IMAGING APPARATUS AND ULTRASONIC IMAGING METHOD
PL3011321T3 (pl) Obrazowanie rentgenowskie z kodowaną przesłoną
GB201408761D0 (en) X-ray imaging apparatus and methods
SG10201801993WA (en) Photoacoustic imaging contrast agent composition
PL2781158T3 (pl) Środek myjący i pielęgnacyjny dla zwierząt użytkowych
GB2510627B (en) Reorientation of cardiac PET images
GB201309498D0 (en) Novel diagnosis and therapy
SG11201603315VA (en) Photoacoustic imaging contrast agent
GB201302884D0 (en) Novel methods for diagnosis and therapy
GB201310458D0 (en) Radiowave Tomographic Imaging Apparatus and Method